DeepCure

Pioneering a New Frontier in Drug Discovery

Spun out of the MIT Media Lab, DeepCure has developed an AI/ML-based drug discovery platform that leverages MolDB, its proprietary database of over 1 trillion chemistries, to find novel small molecule drugs for previously undruggable targets. Instead of merely improving on physics-based modeling or optimizing binding associations, DeepCure leverages novel chemistry space to deliver high quality scaffolds for effective therapeutics.